Prevention & lipids

Polygenic Background Modifies Risk of Coronary Artery Disease Among Individuals With Heterozygous Familial Hypercholesterolemia

JACC AdvPublished Prospective cohort study

Authors' conclusion

In 2 cohort studies involving 1,744 individuals with genetically confirmed HeFH - the largest study to date - risk of CAD varied according to polygenic background, in some cases approaching the risk observed in noncarriers.

Study context

Population
Individuals carrying a heterozygous familial hypercholesterolemia (HeFH) variant and matched family noncarriers from a nationwide screening programme in the Netherlands; replication in UK BiobankUK Biobank replication n = 151,009
Participants
1,315 vs 1,315
Exposure
Polygenic score among HeFH variant carriers; HeFH carriers vs matched family noncarriers
  • HeFH variant carriersn = 1,315
  • Noncarriersn = 1,315reference
Outcome
Incident CAD by polygenic score among HeFH variant carriers
Follow-up
Median 10.2 years
Methodological detailsmatched family noncarriers, replication in UK Biobank
  • Matched family noncarriers
  • Replication in UK Biobank

Main finding

As reported in the abstract

Incident CAD per SD increase
Per SD increase
Hazard ratio (95% CI)
Polygenic score (per SD), HeFH carriers
1.35(1.07–1.70)
LDL-C (per SD), HeFH carriers
1.41(1.17–1.70)

Per SD, as printed

Coronary artery disease (CAD) risk vs noncarriers, lowest polygenic score quintile
1.24-fold (95% CI: 0.64-2.34)
CAD risk vs noncarriers, highest polygenic score quintile
3.37-fold (95% CI: 2.11-5.36)

Observational data: associations, not effects.

Further findings

OutcomeHeFH variant carriersNoncarriersHR (95% CI)
Incident CAD, HeFH carriersvs matched family noncarriers · median follow-up 10.2 years6.4%3.4%1.88 (1.31–2.70)

CAD risk across polygenic score quintiles, UK Biobank carriers (replication)

Lowest quintile vs noncarriers
1.36-fold (95% CI: 0.65-2.85)
Highest quintile vs noncarriers
2.88-fold (95% CI: 1.59-5.20)
  • 429 carriers in the UK Biobank

Original publication

Polygenic Background Modifies Risk of Coronary Artery Disease Among Individuals With Heterozygous Familial Hypercholesterolemia. JACC Adv. Published 28 October 2023. doi:10.1016/j.jacadv.2023.100662

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.